| # | Country | Total Patents | |
|---|---|---|---|
| #1 | New Zealand | 3 | |
| #2 | EPO (European Patent Office) | 2 | |
| #3 | Hong Kong | 2 | |
| #4 | Canada | 1 | |
| #5 | Mexico | 1 | |
| #6 | Philippines | 1 | |
| #7 | Serbia | 1 | |
| #8 | United States | 1 | |
| #9 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials | |
| #5 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Grimm Jan | 10 |
| #2 | Weihofen Andreas | 6 |
| #3 | Hock Christoph | 5 |
| #4 | Engber Thomas | 5 |
| #5 | Weinreb Paul H | 4 |
| #6 | Nitsch Roger | 4 |
| #7 | Rhodes Kenneth | 3 |
| #8 | Qian Fang | 3 |
| #9 | Patel Shailendra | 3 |
| #10 | Maier Marcel | 3 |
| Publication | Filing date | Title |
|---|---|---|
| US2016177390A1 | Genetic and image biomarkets associated with decline in cognitive measures and brain glucose metabolism in populations with alzheimer's disease or those susceptible to developing alzheimer's disease |